The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment
============================================================================================================

* Edmund Poon
* Stefanie Mullins
* Amanda Watkins
* Geoffrey S. Williams
* Jens-Oliver Koopmann
* Gianfranco Di Genova
* Marie Cumberbatch
* Margaret Veldman-Jones
* Shaun E. Grosskurth
* Vasu Sah
* Alwin Schuller
* Corrine Reimer
* Simon J. Dovedi
* Paul D. Smith
* Ross Stewart
* Robert W. Wilkinson